Literature DB >> 23466749

Primary high-grade neuroendocrine carcinoma of the heart.

Gustavo E Guajardo-Salinas1, Javier E Anaya-Ayala, David C Rice, Cesar A Moran, Michael J Reardon.   

Abstract

We report the successful resection of a solitary, apparently primary, high-grade neuroendocrine carcinoma of the heart, in a 70-year-old man who had presented with progressive dyspnea. The tumor occupied the right atrium and almost completely obstructed the superior and inferior venae cavae; it also involved the aortic root and the interatrial septum. To postpone the patient's impending cardiac failure, we resected the gross tumor except in the region of the aortic root and the trigone, which we debulked. We completely reconstructed the right atrium with pericardium and the interatrial septum with a pericardial patch. The patient recovered uneventfully; 18 months postoperatively, he had experienced only local recurrence in the tumor bed. This case shows that the palliative resection of large neuroendocrine tumors of the heart can yield good outcomes and prolong patient survival. To our knowledge, ours is the only report of a high-grade neuroendocrine cardiac tumor of apparently primary origin to have been resected with good palliative results.

Entities:  

Keywords:  Carcinoma, neuroendocrine/surgery; diagnosis, differential; heart neoplasms/diagnosis/epidemiology/pathology/surgery; neuroendocrine tumors/diagnosis; treatment outcome

Mesh:

Year:  2013        PMID: 23466749      PMCID: PMC3568293     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  13 in total

1.  Carcinoid tumor metastatic to the heart.

Authors:  S N Fine; M L Gaynor; O W Isom; A J Dannenberg
Journal:  Am J Med       Date:  1990-11       Impact factor: 4.965

2.  A matter of the heart: myocardial metastases in neuroendocrine tumors.

Authors:  H Jann; T Wertenbruch; U Pape; C Ozcelik; T Denecke; S Mehl; B Wiedenmann; M Pavel
Journal:  Horm Metab Res       Date:  2010-10-22       Impact factor: 2.936

3.  Solitary myocardial metastasis from small-bowel neuroendocrine carcinoma.

Authors:  Chirag N Patel; Alan Anthoney; Darren Treanor; Andrew F Scarsbrook
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

4.  Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study.

Authors:  John D Hainsworth; David R Spigel; Sharlene Litchy; F Anthony Greco
Journal:  J Clin Oncol       Date:  2006-08-01       Impact factor: 44.544

5.  Neoplasms metastatic to the heart: review of 3314 consecutive autopsies.

Authors:  K P Abraham; V Reddy; P Gattuso
Journal:  Am J Cardiovasc Pathol       Date:  1990

6.  Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.

Authors:  P Chu; E Wu; L M Weiss
Journal:  Mod Pathol       Date:  2000-09       Impact factor: 7.842

7.  Surgical outcome in 85 patients with primary cardiac tumors.

Authors:  Faisal G Bakaeen; Michael J Reardon; Joseph S Coselli; Charles C Miller; Jimmy F Howell; Gerald M Lawrie; Rafael Espada; Mahesh K Ramchandani; George P Noon; Donald G Weilbaecher; Michael E DeBakey
Journal:  Am J Surg       Date:  2003-12       Impact factor: 2.565

8.  Heart failure due to right ventricular metastatic neuroendocrine tumor.

Authors:  Marcos F Minicucci; Leonardo A M Zornoff; Marina P Okoshi; Solange P Bueno; Beatriz B Matsubara; Paula S Azevedo; Daniella R Duarte; Sergio A R Paiva; Mariangela Marques; Luiz S Matsubara
Journal:  Int J Cardiol       Date:  2007-03-29       Impact factor: 4.164

9.  Isolated metastatic myocardial carcinoid tumor in a 48-year-old man.

Authors:  Vijaykumar S Kasi; Arshad N Ahsanuddin; Charles Gilbert; Lynn Orr; Jon Moran; Vincent L Sorrell; Arshad N Ahsanudin
Journal:  Mayo Clin Proc       Date:  2002-06       Impact factor: 7.616

10.  Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin.

Authors:  E Mitry; E Baudin; M Ducreux; J C Sabourin; P Rufié; T Aparicio; T Aparicio; P Lasser; D Elias; P Duvillard; M Schlumberger; P Rougier
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

View more
  3 in total

1.  Primary neuroendocrine tumour of the right ventricle presenting with heart failure and cyanosis.

Authors:  Syed Yaseen Naqvi; David Henry; Satoshi Furukawa; Howard Haber
Journal:  BMJ Case Rep       Date:  2016-03-11

2.  Solitary neuroendocrine carcinoma of the heart: a case report.

Authors:  Theresa Wißt; Christian-Friedrich Jehn; Mathias Vierbuchen; Jitka Starekova
Journal:  Eur Heart J Case Rep       Date:  2018-09-12

3.  Long-Term Follow-Up of Significant Improvement After CAPTEM Treatment for Rare Adrenocorticotropin-Producing Cardiac Neuroendocrine Tumor.

Authors:  Lin Lu; Qingqing Meng; Xiaoping Xing; Tao Yuan; Huabing Zhang; Naishi Li; Yining Wang; Yuejuan Cheng; Chunmei Bai; Hao Wang; Xin Cheng; Yu Xiao; Boju Pan; Yuan Li; Jian Sun; Zhiyong Liang; Huijuan Zhu; Renzhi Wang; Zhaolin Lu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-22       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.